Immunohistochemical Investigation of Cyclooxygenase-2 Expression in Rabbit Uterine Adenocarcinoma and the Potential Use of COX-2 Inhibitors in Cancer Therapy
Animals · 06.11.2024 · 14 (22) · 3169
DOI: 10.3390/ani14223169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animals, online erschienen am 06.11.2024. Verfasst von Emanuela Vaccaro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, 80137 Naples, Italy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cyclooxygenase-2 (COX-2) is overexpressed in many human and animal cancers. Selective COX-2 inhibitors have shown antitumoral effects in tumors with a high expression of COX-2. This study evaluates (1) the expression of COX-2 in rabbit uterine adenocarcinomas, (2) the correlation between immunophenotypic expression and histopathological changes, and (3) the post-surgery response to therapy with COX-2 inhibitors. Forty rabbit uteri were divided into three groups: neoplastic, hyperplastic, and normal endometrium. A histological and immunohistochemical score was applied to investigate the tumor’s grade and the COX-2 expression. By histological evaluation, 30 cases of endometrial adenocarcinoma, 5 cases of endometrial hyperplasia and 5 normal endometria were found. Of the six cases of endometrial adenocarcinoma with follow-up available, four received a post-surgical treatment with meloxicam and two were treated by surgery alone. The survival time of the animals treated with meloxicam was longer than that observed in the untreated animals. A statistically significant difference in COX-2 IHS was observed between non-neoplastic endometrium and adenocarcinoma. The progressive increase in COX-2 expression from normal epithelium to carcinoma suggests that upregulation of COX-2 expression may play a role in tumor initiation and progression. Our findings suggest the possible use of COX-2 inhibitors in treating uterine adenocarcinoma in rabbits. Further study will be needed to confirm this hypothesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterinary Medicine and Animal Productions, University of Naples Federico II, 80137 Naples, Italy.
- Vascular Pathobiology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.
- Department of Veterinary Medical Sciences, University of Bologna, Ozzano dell'Emilia, 40126 Bologna, Italy.
ORCID-Profile: Emanuela Vaccaro, Luigi Navas, Giuseppe Piegari, Barbara Brunetti, Orlando Paciello
Zitieren
APA
Vaccaro, E., Navas, L., Ercolano, M., Piegari, G., Di Napoli, E., Papparella, S., Inverso, D., Brunetti, B., Paciello, O., & Russo, V. (2024). Immunohistochemical Investigation of Cyclooxygenase-2 Expression in Rabbit Uterine Adenocarcinoma and the Potential Use of COX-2 Inhibitors in Cancer Therapy. Animals, 14(22), 3169. https://doi.org/10.3390/ani14223169
Vancouver
Vaccaro E, Navas L, Ercolano M, Piegari G, Di Napoli E, Papparella S, et al. Immunohistochemical Investigation of Cyclooxygenase-2 Expression in Rabbit Uterine Adenocarcinoma and the Potential Use of COX-2 Inhibitors in Cancer Therapy. Animals. 2024;14(22):3169. doi:10.3390/ani14223169
BibTeX
@article{Vaccaro2024,
author = {Vaccaro, Emanuela and Navas, Luigi and Ercolano, Martina and Piegari, Giuseppe and Di Napoli, Evaristo and Papparella, Serenella and Inverso, Donato and Brunetti, Barbara and Paciello, Orlando and Russo, Valeria},
title = {Immunohistochemical Investigation of Cyclooxygenase-2 Expression in Rabbit Uterine Adenocarcinoma and the Potential Use of COX-2 Inhibitors in Cancer Therapy},
journal = {Animals},
year = {2024},
volume = {14},
number = {22},
pages = {3169},
doi = {10.3390/ani14223169}
}
EUVIMED